Tabersonine enhances cisplatin sensitivity by modulating Aurora kinase A and suppressing epithelial–mesenchymal transition in triple-negative breast cancer
Article in Pharmaceutical Biology (May 2024)
The most recent citing publications are shown below. View all 13 publications that cite this research output on Dimensions.
Article in Pharmaceutical Biology (May 2024)
Article in Journal of Controlled Release (May 2024)
Article in Applied Sciences (April 2024)